Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)
China
· Delayed Price · Currency is CNY 8.81
+0.04 (0.46%)
Apr 29, 2026, 3:04 PM CST
SHE:002332 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 402.51 | 452.6 | 397.18 | 563.08 | 749.41 | 619.33 | Upgrade
|
| Depreciation & Amortization | 222.56 | 222.56 | 224.25 | 218.91 | 193 | 189.52 | Upgrade
|
| Other Amortization | 2.79 | 2.79 | 4.42 | 2.27 | 2.74 | 4.32 | Upgrade
|
| Loss (Gain) From Sale of Assets | -46.3 | -46.3 | -0.28 | 1.48 | -91.62 | -14.51 | Upgrade
|
| Asset Writedown & Restructuring Costs | 39.7 | 39.7 | 1.31 | 0.42 | 0.91 | 1.68 | Upgrade
|
| Loss (Gain) From Sale of Investments | 26.41 | 26.41 | 8.08 | 7.17 | -49.35 | -29.22 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 10.95 | -7.29 | 4 | - | Upgrade
|
| Other Operating Activities | 181.38 | 14.92 | 39.31 | 42.53 | 32.38 | 25.45 | Upgrade
|
| Change in Accounts Receivable | -275.98 | -275.98 | -280.88 | -203.22 | -129.77 | 69.04 | Upgrade
|
| Change in Inventory | -6.4 | -6.4 | -88.14 | -105.98 | -92.65 | -233.44 | Upgrade
|
| Change in Accounts Payable | -178.12 | -178.12 | 89.6 | 69.36 | -9.79 | 24.19 | Upgrade
|
| Operating Cash Flow | 363.84 | 247.48 | 398.66 | 595.48 | 609.28 | 657.9 | Upgrade
|
| Operating Cash Flow Growth | 18.11% | -37.92% | -33.05% | -2.27% | -7.39% | -16.64% | Upgrade
|
| Capital Expenditures | -182.6 | -209.07 | -207.59 | -234.63 | -282.54 | -248.58 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.67 | 0.76 | 47.26 | 1.31 | 4.03 | 37.74 | Upgrade
|
| Divestitures | 10.46 | 10.46 | - | 48.22 | 69.88 | - | Upgrade
|
| Investment in Securities | -0.8 | -0.5 | -24.3 | -16.33 | 507.04 | 6.53 | Upgrade
|
| Other Investing Activities | 3.21 | 2.21 | 4.21 | 4.81 | 59.67 | -0.38 | Upgrade
|
| Investing Cash Flow | -168.07 | -196.14 | -180.42 | -196.63 | 358.07 | -204.68 | Upgrade
|
| Short-Term Debt Issued | - | - | 3.45 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 414.95 | 5.62 | 1.36 | 198.15 | 433.79 | Upgrade
|
| Total Debt Issued | 505.64 | 414.95 | 9.07 | 1.36 | 198.15 | 433.79 | Upgrade
|
| Long-Term Debt Repaid | - | -270.94 | -174.03 | -158.86 | -584.73 | -808.94 | Upgrade
|
| Net Debt Issued (Repaid) | 91.22 | 144 | -164.97 | -157.5 | -386.58 | -375.16 | Upgrade
|
| Common Dividends Paid | -402.06 | -401.51 | -298.19 | -299.77 | -154.22 | -172.13 | Upgrade
|
| Other Financing Activities | -5.46 | -3.7 | -2.67 | -6.58 | 118.36 | 63.15 | Upgrade
|
| Financing Cash Flow | -316.3 | -261.21 | -465.82 | -463.85 | -422.44 | -484.13 | Upgrade
|
| Foreign Exchange Rate Adjustments | -19.62 | 25.61 | -6.13 | -13.44 | 28.17 | -32.71 | Upgrade
|
| Net Cash Flow | -140.14 | -184.26 | -253.72 | -78.43 | 573.09 | -63.64 | Upgrade
|
| Free Cash Flow | 181.24 | 38.4 | 191.07 | 360.85 | 326.74 | 409.31 | Upgrade
|
| Free Cash Flow Growth | 156.73% | -79.90% | -47.05% | 10.44% | -20.17% | -39.01% | Upgrade
|
| Free Cash Flow Margin | 4.94% | 1.02% | 4.78% | 8.75% | 7.46% | 9.39% | Upgrade
|
| Free Cash Flow Per Share | 0.18 | 0.04 | 0.19 | 0.36 | 0.33 | 0.41 | Upgrade
|
| Cash Income Tax Paid | 296.25 | 293.96 | 254.06 | 286.67 | 423.25 | 380.93 | Upgrade
|
| Levered Free Cash Flow | 335.89 | 209.6 | 136.88 | 389.58 | 279.35 | 310.37 | Upgrade
|
| Unlevered Free Cash Flow | 335.89 | 209.6 | 138.84 | 391.68 | 283.28 | 324.81 | Upgrade
|
| Change in Working Capital | -465.21 | -465.21 | -286.56 | -233.08 | -232.19 | -138.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.